Adipocytokines and CD34 progenitor cells in Alzheimer's disease
about
Degeneration of Dopaminergic Neurons Due to Metabolic Alterations and Parkinson's DiseaseFood for thought: the role of appetitive peptides in age-related cognitive declineEstrogen: a master regulator of bioenergetic systems in the brain and bodyLow plasma leptin in cognitively impaired ADNI subjects: gender differences and diagnostic and therapeutic potential.The therapeutic potential of metabolic hormones in the treatment of age-related cognitive decline and Alzheimer's disease.Repositioning leptin as a therapy for Alzheimer's diseaseOsmotin attenuates amyloid beta-induced memory impairment, tau phosphorylation and neurodegeneration in the mouse hippocampus.Alzheimer's disease promotion by obesity: induced mechanisms-molecular links and perspectivesObesity, leptin, and Alzheimer's diseaseAdiponectin, leptin and IL-1 β in elderly diabetic patients with mild cognitive impairment.Adipocyte-derived factors in age-related dementia and their contribution to vascular and Alzheimer pathologyLeptin Dysfunction and Alzheimer's Disease: Evidence from Cellular, Animal, and Human Studies.Obesity as a risk factor for Alzheimer's disease: the role of adipocytokines.Dietary regulation of PI3K/AKT/GSK-3β pathway in Alzheimer's disease.Serum high-molecular-weight adiponectin level and incident dementia in patients with vascular risk factors.Association of adiponectin, leptin and resistin with inflammatory markers and obesity in dementia.Circulating Progenitor Cells Correlate with Memory, Posterior Cortical Thickness, and Hippocampal Perfusion.The Influence of Adipose Tissue on Brain Development, Cognition, and Risk of Neurodegenerative Disorders.Leptin Regulation of Synaptic Function at Hippocampal TA-CA1 and SC-CA1 Synapses: Implications for Health and Disease.Decreased Levels of Circulating Adiponectin in Mild Cognitive Impairment and Alzheimer’s DiseaseClinicotherapeutic Potential of Leptin in Alzheimer’s Disease and Parkinson’s Disease
P2860
Q26750370-0BAF49CB-48BB-4145-93EC-5A7053A34EDEQ27009988-DFFE048C-88A3-4F35-B863-5FE1537DE9A3Q33623924-89087293-0781-4FD1-B1D8-C432E954DFA6Q33692408-D891FDA5-A931-4F66-8DD0-F59CC267697FQ33851630-A6A9CCC1-E0B6-488A-B073-D3EA1353F13DQ35569809-1F909AAA-CC41-4FD6-97E2-F3AD8A13D9A8Q35793436-A741298D-9C29-401A-876E-F9F0C3206563Q36026292-AF56D82E-5BCF-4CFA-8520-D2CDC549D545Q36587781-2018E726-AA47-44D2-88C4-F15284685015Q36686081-1E83B35A-8B2C-4D5D-8AA7-BA66F5D07A63Q36767745-773B9D92-40EB-43EE-B8F7-4C1844D271E6Q36840174-8268AE58-CA20-4EEB-9378-695AD7A70FDBQ38189680-8BECBD79-A702-496F-8724-BBAFB0785CC1Q38230391-1B8C4F84-E706-4D6E-A61F-633A585C9B30Q38930559-8C514CA9-7BBE-4749-861C-A9BE97533C47Q41039610-C305CFE3-A77B-41B6-B959-A03DA70B5391Q47986845-F848FE65-CCF7-4600-9C4A-54E492433C04Q48103379-87B30E66-9AEB-45FF-9A50-AC0278B7C6CAQ48218464-11775BAE-CBD0-42B8-AC28-03C8CC4C3D0DQ57812922-C4A90AB2-20E2-47A3-BCC6-42CB6B941859Q59048785-1B1BAA22-9CB4-4283-857D-5E5BDB333B3B
P2860
Adipocytokines and CD34 progenitor cells in Alzheimer's disease
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Adipocytokines and CD34 progenitor cells in Alzheimer's disease
@ast
Adipocytokines and CD34 progenitor cells in Alzheimer's disease
@en
type
label
Adipocytokines and CD34 progenitor cells in Alzheimer's disease
@ast
Adipocytokines and CD34 progenitor cells in Alzheimer's disease
@en
prefLabel
Adipocytokines and CD34 progenitor cells in Alzheimer's disease
@ast
Adipocytokines and CD34 progenitor cells in Alzheimer's disease
@en
P2093
P2860
P1433
P1476
Adipocytokines and CD34 progenitor cells in Alzheimer's disease
@en
P2093
Angela Paul
Boris Bigalke
Brigitte Schreitmüller
Christoph Laske
Elke Stransky
Kateryna Sopova
Konstantinos Stellos
Meinrad Gawaz
P2860
P304
P356
10.1371/JOURNAL.PONE.0020286
P407
P577
2011-05-25T00:00:00Z